HOXB8 promotes invasion and metastasis of high-grade serous ovarian cancer via suppression of the KDM6B/C/EBPα signaling axis. [PDF]
Transl Cancer ResXiang L, Lou Y, Wang P, Hu Y, Wang D.
europepmc +1 more source
Comparative study of Exosome Ovarian Cancer auxiliary diagnostic kit (Chemiluminescence) and Serum Tumor Marker CA125 in the diagnosis of Ovarian Epithelial Cell Carcinoma. [PDF]
Pak J Med SciLu W, Yang C, Liu T, Guo L, Tong C.
europepmc +1 more source
Serum miR-200c-3p and miR-6134 as diagnostic biomarkers for epithelial ovarian cancer. [PDF]
Discov OncolKawahara R +5 more
europepmc +1 more source
Correction to "Integrating Thyroid Autoantibodies With CA125 Enhances Diagnostic Precision for Ovarian Endometriosis: A Retrospective Study of 885 Patients". [PDF]
J Obstet Gynaecol Reseuropepmc +1 more source
Biomarkers in Medicine, 2007 A quarter of a century since its discovery, circulating CA125 antigen is recommended for clinical use in the USA for ovarian cancer screening of high-risk women with ovaries, despite its limited sensitivity and specificity. Recent findings suggest that CA125 might also serve as a predictive marker for pre-invasive ovarian carcinoma. Methods to quantify
Nathalie Scholler
exaly +3 more sources
CA125 and Ovarian Cancer: A Comprehensive Review [PDF]
Cancers, 2020 Ovarian cancer is the second most lethal gynecological malignancy. The tumour biomarker CA125 has been used as the primary ovarian cancer marker for the past four decades. The focus on diagnosing ovarian cancer in stages I and II using CA125 as a diagnostic biomarker has not improved patients’ survival.
Parsa Charkhchi +2 more
exaly +4 more sources
Exploring the Glycosylation of Serum CA125 [PDF]
International Journal of Molecular Sciences, 2013 Ovarian cancer is the most lethal gynaecologic cancer affecting women. The most widely used biomarker for ovarian cancer, CA125, lacks sensitivity and specificity. Here, we explored differences in glycosylation of CA125 between serum from patients with ovarian cancer and healthy controls.
Radka Saldova +2 more
exaly +3 more sources
Related searches:
This review covers the literature on CA125 and endometriosis; data on CA125 and oncology are not discussed. In normal women, plasma concentrations of CA125 are increased slightly at ovulation and significantly during menstruation. Marked increases are observed during pregnancy and following peritoneal irritation by infection or surgery.
M, Muyldermans +2 more
openaire +2 more sources
The prognostic significance of the CA125 nadir in patients that achieve a CA125 response
Journal of Clinical Oncology, 20045001 Background:In a series of patients (pts) who had received chemotherapy for epithelial ovarian cancer (EOC) at one hospital, it was observed that survival varied between the groups that attaine...
S. M. Crawford +5 more
openaire +1 more source
CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients
Gynecologic Oncology, 2007Simon A Gayther +2 more
exaly +2 more sources